Chemokines as novel therapeutic targets in inflammatory diseases
Authors:
- Maureen N. AjueborMAMaureen N. Ajuebor
- Mark G. SwainMSMark G. Swain
- Mauro PerrettiMPMauro Perretti
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 63 (7) , 1191-1196
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Role of chemokines and chemokine receptors in the gastrointestinal tractImmunology, 2002
- The role of chemokines in the immunopathology of the liverImmunological Reviews, 2000
- Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesisThe Journal of Pathology, 2000
- Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptorEuropean Journal of Immunology, 2000
- Gastric Metaplasia in the Duodenal Bulb Shows Increased Mucosal Interleukin-8 Activity in Helicobacter pylori-Positive Duodenal Ulcer PatientsScandinavian Journal of Gastroenterology, 2000
- Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.Journal of Clinical Investigation, 1998
- Gastric corpus IL‐8 concentration and neutrophil infiltration in duodenal ulcer patientsAlimentary Pharmacology & Therapeutics, 1997
- Mucosal Chemokine Activity inHelicobacter pylori InfectionJournal of Clinical Gastroenterology, 1997
- Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survivalJournal of Hepatology, 1996
- Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitroGastroenterology, 1995